← SynDRA
SEMAXANIB
SynDRA canonical compound SYN0000669 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
FGFR1 | FLT1 | FLT3 | KDR | KIT | MET | PDGFRA | PDGFRB | RET
Mechanism of action
VEGFR inhibitor
All known targets
FLT1
KDR
KIT
FGFR1
FLT3
FLT4
MET
PDGFRA
PDGFRB
RET
Mechanisms of action (all sources)
KIT INHIBITOR
Stem cell growth factor receptor inhibitor
FLT1 INHIBITOR
Vascular endothelial growth factor receptor inhibitor
FLT4 INHIBITOR
KDR INHIBITOR
VEGFR inhibitor
Cross-references
PubChem CID:
5329098
ChEMBL:
CHEMBL276711
DrugBank:
DB06436
ChEBI:
91083
KEGG:
D05819
PDB:
X2M
Wikipedia:
Semaxanib
Synonyms
Semaxinib
SU-5416
NSC-696819
SU005416
SU5416
Semoxind
Semaxanib (SU5416)
(Z)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
TSU-16
Z-Semaxanib
NSC 696819
(Z)-SU 5416
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon
NCGC00094381-03
3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one
3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
DTXCID9021132
Semaxnib
MFCD09763655
Semaxanib [INN]
SMR000568416
VEGF Receptor 2 Kinase Inhibitor III
CAS-204005-46-9
SR-01000076044
Semaxanib (USAN/INN)
Semaxanib [USAN:INN]
methylene]-2H-indol-2-one
UNII-71IA9S35AJ
test2
(Z)-Semaxanib
2x2m
Semaxanib; SU5416
SEMAXANIB [USAN]
Semaxanib (SU5416)?
SEMAXANIB [MART.]
S 8442
SEMAXANIB [WHO-DD]
Lopac0_001110
Look up SEMAXANIB in the interactive SynDRA portal →